We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
The International Journal of Oral & Maxillofacial Implants
Login:
username:

password:

Plattform:

Forgotten password?

Registration

Int J Oral Maxillofac Implants 33 (2018), No. 2     5. Apr. 2018
Int J Oral Maxillofac Implants 33 (2018), No. 2  (05.04.2018)

Page 351-356, doi:10.11607/jomi.6015, PubMed:29253039


The Research of Dishevelled-2 in Dental Implant Osseointegration of Hyperlipidemic Rats
Dong, Xiaofei / Wang, Zhifeng / Wang, Hui / Lan, Jing
Purpose: To investigate the influence of dishevelled-2 (Dvl2) protein and the phosphorylation and ubiquitination of Dvl2 on dental implant osseointegration in hyperlipidemic rats.
Materials and Methods: Thirty-six Wistar rats were divided equally into two groups: an experimental group fed with a high-fat diet for 8 weeks and a control group fed with a normal diet for 8 weeks. Serum lipids were detected, and titanium implants were placed into bilateral proximal metaphysis of rats' femurs. At 1, 3, and 5 days after implantation, rats were sacrificed, and 1 mm of bone around each implant was obtained. Real-time polymerase chain reaction of runt-related transcription factor 2 (Runx2), Cathepsin K, and Dvl2 was performed. Western blot of Dvl2, phosphorylation, and ubiquitination of Dvl2 was also performed.
Results: In the experimental group, the expressions of Runx2, Dvl2, and phosphorylation of Dvl2 were lower (P < .05), while that of Cathepsin K and ubiquitination of Dvl2 were higher than those in the control group (P < .05).
Conclusion: Hyperlipidemia suppressed the dental implant osseointegration. This inhibition may be modulated by downregulated Dvl2, phosphorylation of Dvl2, and upregulated ubiquitination of Dvl2.

Keywords: dishevelled-2, hyperlipidemia, implant osseointegration, rats, Wnt signaling pathway